Nicholas Downing

Bain Capital Life Sciences thesis

more INVESTOR LOGIN LOCATIONS SEARCH CLOSE Bain Capital Life Sciences About Approach Portfolio People News Contact Scroll Up to Approach Portfolio Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe. Portfolio listing as of Jan 1, 2026. Layout: Status: All All Active Former Abcuro 2023 ADARx Pharmaceuticals 2023 Affera 2021 Affinivax 2020 Aiolos Bio 2023 Alkeus Pharmaceuticals 2022 Amunix Pharmaceuticals 2021 Amylyx Pharmaceuticals 2021 Angitia 2024 Annexon Biosciences 2018 Apreo 2025 Apti

Sector and stage focus

• Series B: Health & Hospital Services, Digital Health, Health IT
• Series A: Health IT, Health & Hospital Services, Digital Health
• general: Boston / New England
• Seed: Health IT, Digital Health, Health & Hospital Services

Is Nicholas Downing a fit for your round?

Upload your pitch deck and see whether Nicholas Downing appears in your top 20 matches.